MDGL - Company ID 0001157601
The table below shows MADRIGAL PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $227.03M | $295.69M | $186.19M | $183.65M | $232.68M | $494.60M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $187.36M | $113.28M | $79.23M | $61.43M | $30.46M | $6.90M |
| Inventory | $112.07M | $69.32M | $63.50M | $55.24M | $8.71M | $7.07M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.18B |
| $1.35B |
| $1.00B |
| $987.98M |
| $1.06B |
| $1.09B |
| Property, plant & equipment | $8.04M | $2.91M | $1.61M | $1.90M | $2.27M | $1.70M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.23B | $1.36B | $1.02B | $996.63M | $1.07B | $1.10B |
| Accounts payable | $60.80M | $44.94M | $37.98M | $42.06M | $45.97M | $8.99M |
| Total current liabilities | $338.26M | $391.41M | $196.50M | $167.24M | $177.85M | $125.16M |
| Long-term debt | $340.33M | $339.75M | $118.38M | $118.00M | $117.09M | $116.61M |
| Total liabilities | $683.87M | $736.73M | $319.40M | $285.99M | $296.11M | $242.67M |
| Retained earnings | -$2.18B | -$2.03B | -$1.92B | -$1.88B | -$1.74B | -$1.64B |
| Total equity | $543.45M | $625.73M | $695.98M | $710.64M | $777.15M | $857.12M |